Vanguard Group Inc Vericel Corp Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Vericel Corp stock. As of the latest transaction made, Vanguard Group Inc holds 3,483,896 shares of VCEL stock, worth $197 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,483,896
Previous 3,444,682
1.14%
Holding current value
$197 Million
Previous $158 Million
6.86%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding VCEL
# of Institutions
276Shares Held
48.5MCall Options Held
91.8KPut Options Held
23.2K-
Black Rock Inc. New York, NY8.06MShares$455 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.83MShares$216 Million3.54% of portfolio
-
State Street Corp Boston, MA2.43MShares$137 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.37MShares$134 Million0.02% of portfolio
-
Conestoga Capital Advisors, LLC2.08MShares$117 Million1.21% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.67B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...